Affinage

CUX2

Homeobox protein cut-like 2 · UniProt O14529

Length
1486 aa
Mass
161.7 kDa
Annotated
2026-06-09
40 papers in source corpus 19 papers cited in narrative 19 extracted findings
Cross-family judge vs UniProt: tie faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CUX2 is a Cut-repeat/homeodomain transcription factor that governs the genesis, differentiation, and functional maturation of upper-layer cortical neurons while also operating in other tissues as a sequence-specific DNA-binding regulator (PMID:8798433, PMID:18033766). Through three Cut repeats and a homeodomain it binds DNA in a sequence-specific but rapid and transient manner, functioning predominantly as a transcriptional repressor though it activates targets in specific contexts (PMID:8798433, PMID:15656993). In the developing nervous system CUX2 acts cell-autonomously to drive cell-cycle exit of intermediate neuronal precursors—binding the Neurod and p27(Kip1) promoters—and to control neuroblast formation and cell-fate determination, downstream of Notch signaling (PMID:18033766, PMID:18223201, PMID:19542352). In post-mitotic layer II–III neurons it intrinsically controls dendrite branching, spine development, and synapse formation, in part by directly regulating the chromatin-remodeling genes Xlr3b and Xlr4b, and it physically interacts with the CUX1-derived CASP isoform to modulate excitatory synaptic transmission (PMID:20510857, PMID:35581205). Beyond transcription, CUX2 Cut repeats directly stimulate the base-excision-repair glycosylase OGG1 on oxidized DNA, and CUX2 is required—alongside ATF4-driven double-strand-break repair programs—for the resilience of layer 2/3 excitatory neurons against oxidative and inflammatory DNA damage (PMID:26221032, PMID:41922773, PMID:41922774). In liver, CUX2 enforces sex-biased gene expression by activating female-biased genes and repressing male-biased genes, the latter through competitive displacement of HNF6 from co-occupied binding sites (PMID:22966202, PMID:26218442). Cux2 expression is itself controlled by the upstream activators Lmx1a and Lhx2 acting through conserved enhancer elements (PMID:30770393, PMID:31708105).

Mechanistic history

Synthesis pass · year-by-year structured walk · 14 steps
  1. 1996 Medium

    Established that CUX2 is a sequence-specific DNA-binding protein, defining its molecular identity as a Cut-repeat/homeodomain factor.

    Evidence GST fusion protein DNA-binding assay on NCAM promoter oligonucleotides

    PMID:8798433

    Open questions at the time
    • No in vivo target genes identified
    • Functional consequence of binding unknown
  2. 2004 Medium

    Distinguished CUX2 from its paralog CUX1 biochemically, showing CUX2 makes more rapid/transient DNA contacts and acts exclusively as a repressor in this cellular context.

    Evidence In vitro DNA binding with purified Cut-repeat fusions plus cell-based reporter assays in NIH3T3

    PMID:15656993

    Open questions at the time
    • Repressor-only behavior is context-dependent (later contexts show activation)
    • No processed isoform detected but mechanism of transient binding unexplained
  3. 2007 High

    Defined CUX2's cell-autonomous role in cortical neurogenesis—controlling cell-cycle exit of intermediate precursors independently of CUX1.

    Evidence Cux2-/- mice, overexpression, BrdU cell-cycle assays, Cux1/Cux2 double-mutant epistasis

    PMID:18033766

    Open questions at the time
    • Direct transcriptional targets in SVZ not identified here
    • Molecular mechanism of cycle exit left to later work
  4. 2008 High

    Linked CUX2's proliferation control to direct transcriptional targets and extended its role to spinal neurogenesis.

    Evidence ChIP on Neurod and p27(Kip1) promoters with reciprocal gain/loss-of-function mouse mutants

    PMID:18223201 PMID:18327765

    Open questions at the time
    • Direct vs. indirect regulation of Reelin interneuron specification unresolved
    • Redundancy with CUX1 complicates target attribution
  5. 2009 Medium

    Placed Cux2 downstream of Notch signaling in dorsal interneuron formation, embedding it in a developmental signaling cascade.

    Evidence Loss-of-function mouse studies with Notch pathway manipulation and genetic epistasis

    PMID:19542352

    Open questions at the time
    • Direct Notch-to-Cux2 transcriptional link not demonstrated
    • Mechanism of interneuron fate control unspecified
  6. 2010 High

    Showed CUX2 acts in post-mitotic neurons to build dendrites, spines, and synapses via direct regulation of chromatin-remodeling genes, connecting it to circuit function and behavior.

    Evidence KO/KD, morphology, electrophysiology, target analysis (Xlr3b/Xlr4b), behavioral testing

    PMID:20510857

    Open questions at the time
    • Full target network beyond Xlr3b/Xlr4b unknown
    • How transcriptional changes translate to spine morphology not mechanistically resolved
  7. 2012 High

    Identified CUX2 as a sex-specific transcriptional regulator in liver, revealing a repression mechanism via competition at male-biased regulatory regions.

    Evidence Adenoviral overexpression, siRNA knockdown, ChIP-seq cistrome mapping

    PMID:22966202

    Open questions at the time
    • Competitive displacement inferred from co-occupancy, not yet directly shown
    • Hormonal/STAT5 upstream control not fully defined here
  8. 2014 Medium

    Resolved paralog division of labor in dendrite development, assigning apical compartment control to CUX2 and basal to CUX1.

    Evidence In vivo reciprocal loss/gain-of-function with apical vs. basal dendrite morphometry

    PMID:25059644

    Open questions at the time
    • Molecular basis of compartment specificity unknown
    • Differential target genes not identified
  9. 2015 High

    Revealed a non-transcriptional function: CUX2 Cut repeats directly stimulate OGG1-mediated base-excision repair of oxidized DNA, protecting neurons from oxidative damage.

    Evidence In vitro OGG1 enzymatic assays with purified CUX2 fragments plus cellular KD and ectopic expression with DNA damage quantification

    PMID:26221032

    Open questions at the time
    • Whether full-length CUX2 acts identically in vivo not fully separated from transcriptional roles
    • Structural basis of OGG1 stimulation unresolved
  10. 2015 High

    Mechanistically demonstrated competitive DNA-binding displacement of HNF6 by CUX2 as the basis for repressing male-biased liver genes.

    Evidence Cell-based transfection, in vitro EMSA, and HNF6/CUX2 ChIP-seq cistrome comparison

    PMID:26218442

    Open questions at the time
    • In vivo functional consequence of displacement on each target not fully mapped
    • Cooperative vs. purely competitive interplay at all sites unclear
  11. 2019 Medium

    Identified the upstream activators that drive region- and layer-specific Cux2 expression, defining how the factor is positioned developmentally.

    Evidence In vivo and in vitro enhancer reporter assays with site-directed mutation of Lmx1a and Lhx2 binding sites

    PMID:30770393 PMID:31708105

    Open questions at the time
    • Combinatorial inputs to the enhancers not fully enumerated
    • Whether Lmx1a/Lhx2 act directly or via cofactors not fully resolved
  12. 2019 Medium

    Extended CUX2 as a direct transcriptional activator of Raldh2 and Hoxb genes patterning the forelimb field, demonstrating context-dependent activator function outside the nervous system.

    Evidence siRNA knockdown and gain-of-function (including CUX2-VP16) in chick with positional phenotyping

    PMID:30651234

    Open questions at the time
    • Direct promoter binding not shown for all targets
    • Generality of activator function across tissues unclear
  13. 2022 Medium

    Expanded CUX2's transcriptional repertoire to ADCY1 and KDM5B in cancer contexts and established a physical interaction with the CASP isoform regulating excitatory transmission.

    Evidence ChIP, dual-luciferase, gain/loss-of-function and xenografts (ADCY1, KDM5B); Co-IP, conditional KO, electrophysiology (CASP)

    PMID:35581205 PMID:35881915 PMID:36242624

    Open questions at the time
    • CASP interaction is a single Co-IP without reciprocal/structural validation
    • Whether tumor-suppressive roles are direct or secondary to broad transcriptional output unclear
  14. 2026 High

    Integrated CUX2's repair and identity functions, showing CUX2+ layer 2/3 neurons depend on CUX2- and ATF4-driven DNA repair to survive oxidative/inflammatory damage.

    Evidence Demyelination/inflammation mouse models, conditional Atf4 knockout, interferon-γ ROS/DNA damage assays, ATM phosphorylation analysis

    PMID:41922773 PMID:41922774

    Open questions at the time
    • Direct molecular link between CUX2 transcription and double-strand-break repair machinery not fully defined
    • Relationship between CUX2-OGG1 BER role and ATF4 DSB-repair axis not reconciled

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CUX2 mechanistically switches between transcriptional repressor and activator, and how its direct DNA-repair-stimulating activity integrates with its transcriptional outputs in vivo, remains unresolved.
  • No structural model of CUX2 on DNA or in complex with OGG1
  • Determinants of context-specific activation vs. repression unknown
  • Direct in vivo targets in most tissues incompletely mapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 6 GO:0003677 DNA binding 5 GO:0098772 molecular function regulator activity 1
Localization
GO:0005634 nucleus 3
Pathway
R-HSA-74160 Gene expression (Transcription) 5 R-HSA-1266738 Developmental Biology 4 R-HSA-73894 DNA Repair 3 R-HSA-112316 Neuronal System 2
Partners

Evidence

Reading pass · 19 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1996 CUX2 protein contains three Cut repeat domains and one homeodomain; a GST fusion protein containing the C-terminal Cut repeat and homeodomain of CUX2 binds DNA in a sequence-specific manner to oligonucleotides derived from the NCAM gene promoter. In vitro DNA binding assay using GST fusion protein The Journal of biological chemistry Medium 8798433
2004 Biochemical characterization showed that CUX2 Cut repeat domains (CR1CR2, CR2CR3HD, CR3HD) have similar DNA-binding specificity to corresponding CUX1 domains but make more rapid and transient interactions with DNA. CUX2 functions exclusively as a transcriptional repressor in NIH3T3 cells (unlike CUX1 which can activate or repress), and no N-terminally processed p110-equivalent isoform was detected. In vitro DNA binding assays with purified fusion proteins; cell-based transcriptional reporter assays Gene Medium 15656993
2007 CUX2 controls cell cycle exit of intermediate neuronal precursors in the cortical SVZ in a cell-autonomous manner; Cux2-/- mice show excessive SVZ neuronal precursor expansion and increased upper layer neuron number, while this function is independent of CUX1 (demonstrated by Cux1-/-;Cux2-/- double mutant analysis). Genetic knockout (Cux2-/- mice), overexpression studies, BrdU cell-cycle re-entry assays, double mutant epistasis Cerebral cortex High 18033766
2008 CUX2 directly binds the Neurod and p27(Kip1) promoters in vivo, and regulates cell-cycle progression of neural progenitors as well as neuroblast formation and cell-fate determination in the spinal cord. Loss-of-function causes smaller spinal cords with reduced Neurod and p27(Kip1) activity; gain-of-function enlarges spinal cord with enhanced neuroblast formation. Chromatin immunoprecipitation (ChIP), loss-of-function mouse mutants, gain-of-function transgenic mice Development High 18223201
2008 CUX1 and CUX2 together are required for specification of Reelin-expressing cortical interneurons; Cux1-/-;Cux2-/- double mutant mice completely lack Reelin expression in cortical layers II-IV, while single mutants are unaffected, demonstrating essential but redundant roles. Genetic double knockout mice, immunohistochemistry for Reelin Developmental neurobiology Medium 18327765
2009 Notch signaling regulates Cux2 expression in the spinal cord, and Cux2 acts downstream of Notch signaling to regulate dorsal interneuron formation; loss-of-function of Cux2 reduces dorsal spinal cord interneuron numbers. Loss-of-function mouse studies, Notch pathway manipulation, genetic epistasis Development Medium 19542352
2010 CUX2 is an intrinsic regulator of dendrite branching, dendritic spine development, and synapse formation in cortical layer II-III neurons; Cux2-/- mice show abnormal dendrites and synapses correlating with reduced synaptic function and working memory defects. CUX2 directly regulates expression of chromatin remodeling genes Xlr3b and Xlr4b as part of this mechanism. Knockout and knockdown studies, morphological analysis, electrophysiology, molecular analysis of downstream targets, behavioral testing Neuron High 20510857
2012 CUX2 functions as a sex-specific transcriptional regulator in female liver, activating female-biased genes (including A1bg, Cyp2b9, Cyp3a44, Tox, Trim24 by direct binding) and repressing male-biased genes. CUX2 chromatin binding is enriched at regions with male-biased DNase hypersensitivity and male-enriched STAT5 binding sites, suggesting competitive displacement as a repression mechanism. Adenoviral overexpression, siRNA knockdown, ChIP-seq, chromatin binding analysis Molecular and cellular biology High 22966202
2014 CUX2 specifically regulates apical dendrite development in cortical layer II-III neurons, while CUX1 preferentially regulates basal dendrite development; demonstrated by in vivo loss- and gain-of-function analysis showing distinct compartment-specific effects of each paralog. In vivo loss-of-function and gain-of-function analysis, morphological analysis of apical vs. basal dendrites Developmental neurobiology Medium 25059644
2015 CUX2 Cut repeat domains stimulate OGG1 (8-oxoguanine DNA glycosylase 1) by increasing OGG1 binding to 8-oxoguanine-containing DNA and stimulating both its glycosylase and AP lyase activities in vitro; CUX2 knockdown in neurons increases oxidative DNA damage, while ectopic expression of CUX2 Cut repeats accelerates DNA repair and reduces oxidative DNA damage. In vitro biochemical assay of OGG1 activity with purified CUX2 fragments, siRNA knockdown, ectopic expression, DNA damage quantification The Journal of biological chemistry High 26221032
2015 CUX2 inhibits HNF6 transcriptional regulation of sex-specific gene promoters (CYP2C11 and CYP2C12) through competition for DNA binding, as demonstrated by EMSA; approximately 90% of CUX2 genome-wide binding sites are co-bound by HNF6, with CUX2 displacement of HNF6 proposed as a mechanism for repression of male-biased genes. Cell-based transfection assays, in vitro EMSA, ChIP-seq (HNF6 and CUX2 cistromes) Molecular endocrinology High 26218442
2019 Lmx1a transcription factor directly activates Cux2 expression through binding to a conserved intronic enhancer in the cortical hem; Lmx1a-binding sites within the enhancer are required for activity in vivo, and mis-expression of Lmx1a in hippocampal progenitors increases Cux2 enhancer activity outside the cortical hem. In vitro reporter assays, in vivo enhancer reporter assays, bioinformatic identification of TF binding sites, mis-expression experiments Development Medium 30770393
2019 CUX2 directly activates expression of Raldh2 and Hoxb genes in the lateral plate mesoderm to refine the forelimb field position along the anterior-posterior axis; knockdown causes caudal shift of forelimb bud, while overexpression or constitutively active CUX2-VP16 causes rostral shift. siRNA knockdown in chick, gain-of-function with CUX2 and CUX2-VP16, functional analysis of downstream targets Biology open Medium 30651234
2019 Lhx2 transcription factor acts as a transcriptional activator of Cux2 through a conserved 220 bp enhancer region (Cux2-E1) that controls cortical layer II-IV-specific expression; demonstrated by in vivo reporter assays and identification of the minimal enhancer. BAC transgenic mice, comparative genome analysis, in vivo reporter assays, immunohistochemistry Biochemical and biophysical research communications Medium 31708105
2022 CUX2 protein physically interacts with CASP (a short CUX1 isoform), as shown by co-immunoprecipitation; both are co-expressed in excitatory neurons of the entorhinal cortex. CUX2 knockout mice show increased excitatory cell numbers in entorhinal cortex and enhanced glutamatergic synaptic transmission to hippocampus, and CUX2 missense variants show abnormal localization in human cell culture. Co-immunoprecipitation, conditional knockout mice, electrophysiology, cell localization analysis Scientific reports Medium 35581205
2022 CUX2 directly binds the ADCY1 promoter to activate its transcription, as shown by ChIP and dual-luciferase reporter assays; CUX2 overexpression suppresses glioma cell proliferation, migration, and invasion in a manner dependent on ADCY1 upregulation. ChIP assay, dual-luciferase reporter assay, gain- and loss-of-function experiments, xenograft mouse model Experimental brain research Medium 36242624
2022 CUX2 directly activates KDM5B transcription; KDM5B in turn represses SOX17 through histone demethylation, establishing a CUX2/KDM5B/SOX17 regulatory axis in breast cancer cells. ChIP and dual-luciferase reporter assays confirmed CUX2 binding to the KDM5B promoter. ChIP assay, dual-luciferase reporter assay, gain- and loss-of-function, Western blotting, in vivo xenograft Endocrinology Medium 35881915
2026 CUX2 function is required for resilience of cortical L2/3 excitatory neurons during neuroinflammation; Cux2 and Atf4 act in neurons to enhance DNA double-strand break repair. Interferon-γ elevates reactive oxygen species causing DNA damage and selective depletion of CUX2+ L2/3 neurons in mice. Mouse models of demyelination/inflammation, loss-of-function studies, in vitro interferon-γ treatment, DNA damage assays Nature High 41922773
2026 ATF4, whose transcriptional targets include DNA repair components CIRBP, UBA52, and EBF1, is specifically required for development of CUX2+ upper cortical layer 2/3 neurons; pan-cortical ATF4 knockout (Emx1-Cre;Atf4fl/fl) selectively eliminates CUX2+ neurons, and CIRBP is required for normal phosphorylation of ATM during DNA damage responses. Conditional knockout mice (Emx1-Cre;Atf4fl/fl), transcriptional target identification, ATM phosphorylation assays Nature High 41922774

Source papers

Stage 0 corpus · 40 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2004 Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. The Journal of comparative neurology 417 15452856
2010 Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 247 20510857
2004 Dynamics of Cux2 expression suggests that an early pool of SVZ precursors is fated to become upper cortical layer neurons. Cerebral cortex (New York, N.Y. : 1991) 190 15238450
2007 Cux-2 controls the proliferation of neuronal intermediate precursors of the cortical subventricular zone. Cerebral cortex (New York, N.Y. : 1991) 96 18033766
2015 Lineage Tracing Using Cux2-Cre and Cux2-CreERT2 Mice. Neuron 71 25996136
1996 Primary structure, neural-specific expression, and chromosomal localization of Cux-2, a second murine homeobox gene related to Drosophila cut. The Journal of biological chemistry 69 8798433
2012 Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes. Molecular and cellular biology 64 22966202
2008 Cux2 (Cutl2) integrates neural progenitor development with cell-cycle progression during spinal cord neurogenesis. Development (Cambridge, England) 58 18223201
2014 Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II-III cortical neurons. Developmental neurobiology 51 25059644
2015 CUX2 protein functions as an accessory factor in the repair of oxidative DNA damage. The Journal of biological chemistry 47 26221032
2008 Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. Developmental neurobiology 45 18327765
2006 Expression of Cux-1 and Cux-2 in the developing somatosensory cortex of normal and barrel-defective mice. The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 44 16419078
2011 The transcription factor Cux2 marks development of an A-delta sublineage of TrkA sensory neurons. Developmental biology 39 21945863
2004 Biochemical characterization of the mammalian Cux2 protein. Gene 37 15656993
2003 Dynamic expression of murine Cux2 in craniofacial, limb, urogenital and neuronal primordia. Gene expression patterns : GEP 35 12971989
2015 Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver. Molecular endocrinology (Baltimore, Md.) 34 26218442
2003 CDP-2,3-Di-O-geranylgeranyl-sn-glycerol:L-serine O-archaetidyltransferase (archaetidylserine synthase) in the methanogenic archaeon Methanothermobacter thermautotrophicus. Journal of bacteriology 32 12562787
2018 The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant. Annals of neurology 23 29630738
2005 Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 22 15389760
2014 Cux2 acts as a critical regulator for neurogenesis in the olfactory epithelium of vertebrates. Developmental biology 21 24512687
2018 A recurrent de novo CUX2 missense variant associated with intellectual disability, seizures, and autism spectrum disorder. European journal of human genetics : EJHG 20 29795476
2009 Cux2 functions downstream of Notch signaling to regulate dorsal interneuron formation in the spinal cord. Development (Cambridge, England) 20 19542352
2014 Cux2 activity defines a subpopulation of perinatal neurogenic progenitors in the hippocampus. Hippocampus 19 25252086
2021 Adult Upper Cortical Layer Specific Transcription Factor CUX2 Is Expressed in Transient Subplate and Marginal Zone Neurons of the Developing Human Brain. Cells 13 33671178
2022 CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate. Scientific reports 12 35581205
2020 CUX2, BRAP and ALDH2 are associated with metabolic traits in people with excessive alcohol consumption. Scientific reports 11 33093602
2019 Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex. Biochemical and biophysical research communications 11 31708105
2001 CUX2, a potential regulator of NCAM expression: genomic characterization and analysis as a positional candidate susceptibility gene for bipolar disorder. American journal of medical genetics 11 11353453
2019 Lmx1a drives Cux2 expression in the cortical hem through activation of a conserved intronic enhancer. Development (Cambridge, England) 9 30770393
2018 CUX2 functions as an oncogene in papillary thyroid cancer. OncoTargets and therapy 9 30636884
2022 CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer. Endocrinology 7 35881915
2019 Cux2 refines the forelimb field by controlling expression of Raldh2 and Hox genes. Biology open 7 30651234
2016 Cux2 serves as a novel lineage marker of granule cell layer neurons from the rhombic lip in mouse and chick embryos. Developmental dynamics : an official publication of the American Association of Anatomists 7 27198720
2022 Novel Variant Expands the Clinical Spectrum of CUX2-Associated Developmental and Epileptic Encephalopathies. Frontiers in genetics 5 35846140
2019 Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population. Pharmacogenetics and genomics 5 30720667
2023 Androgen-Dependent Expression of CUX2 mRNA in the Pig Liver Is Associated with That of Drug Metabolizing Enzymes and Drug Transporters. Biological & pharmaceutical bulletin 4 36858577
2022 CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription. Experimental brain research 2 36242624
2026 DNA damage burden causes selective CUX2 neuron loss in neuroinflammation. Nature 1 41922773
2026 Expansion of outer cortical CUX2 neurons requires adaptations for DNA repair. Nature 1 41922774
2025 A novel frameshift CUX2 variant in a patient with epilepsy and global developmental delay: Phenotypic and genotypic expansion. European journal of medical genetics 0 41344425

Missed literature

Know a paper Affinage missed for CUX2? Flag it for the maintainers and the community.

No submissions yet.